GC

GlucoTrack IncNASDAQ GCTK Stock Report

Last reporting period 30 Sep, 2023

Updated 26 Nov, 2024

Last price

Market cap $B

0.013

Micro

Exchange

XNAS - Nasdaq

GCTK Stock Analysis

GC

Uncovered

GlucoTrack Inc is uncovered by Eyestock quantitative analysis.

Market cap $B

0.013

Dividend yield

Shares outstanding

15.477 B

GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The firm is focused on the design, development and commercialization of non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company has developed a non-invasive blood glucose monitor, the GlucoTrack Model DF-F glucose monitoring device, which is designed to help people with diabetes obtain blood glucose level readings without the pain, inconvenience, cost and difficulty of conventional (invasive) spot finger stick devices. The firm operates in Europe, and Asia and Pacific. The GlucoTrack model DF-F utilizes a combination of ultrasound, electromagnetic and thermal technologies to obtain blood glucose measurements in less than one minute through a small sensor that is clipped onto one's earlobe and connected to a small, handheld control and display unit, all without drawing blood.

View Section: Eyestock Rating